Benjamin D. Goodlett

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease

Jin‐Kuk Kim, Chunguang Hu, Christelle Moufawad El Achkar et al. · New England Journal of Medicine · 2019 · 772 citations · Full text

Genetic Diseases, Neurodegenerative Diseases, Miracle Foundation +13

Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study

Marja Puurunen, Jerry Vockley, Shawn Searle et al. · Nature Metabolism · 2021 · 146 citations

Engineering, Medicine, First-in-human Phase 1/2A +8

An overview of the “Positive Action for Today's Health” (PATH) trial for increasing walking in low income, ethnic minority communities

Dawn K. Wilson, Nevelyn N. Trumpeter, Sara M. St. George et al. · Contemporary Clinical Trials · 2010 · 38 citations

Physical Activity, Health Care Disparity, Ethnic Minority Communities +16

Temperament, Personality, and Quality of Life in Pediatric Cancer Patients

Felicity W. K. Harper, Benjamin D. Goodlett, Christopher J. Trentacosta et al. · Journal of Pediatric Psychology · 2014 · 33 citations · Full text

First 1.5 years of pegvaliase clinic: Experiences and outcomes

Stephanie Sacharow, Cassandra Papaleo, Benjamin D. Goodlett et al. · Molecular Genetics and Metabolism Reports · 2020 · 25 citations · Full text